All news articles for October 2019

(Image: Getty/BrianAJackson)

FDA guidance ‘a step in the right direction’

By Melissa Fassbender

The FDA has published the second in a series of guidance documents that aim to accelerate research and the use of patient input to inform clinical development programs, says Iqvia head.

(Image: Getty/kunertus)

Charles River signs on to Dementia Consortium

By Melissa Fassbender

Charles River Laboratories recently announced that Alzheimer’s Research UK selected the company to join the Dementia Consortium to help researchers progress projects to in vivo proof of concept.

(Image: Getty/Kirtchanut)

New clinical trial firm formed following 3-company merger

By Melissa Fassbender

Three organizations have merged to form Apex Innovative Sciences, an independent clinical trial site operator focused on Phase I-IV studies for central nervous system indications and other therapeutic areas, including neurology, psychiatry, addiction,...

Follow us

Products

View more

Webinars